Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006530
Filing Date
2025-05-06
Accepted
2025-05-06 17:04:48
Documents
59
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20250331x10q.htm   iXBRL 10-Q 1255215
2 EX-31.1 ptgx-20250331xex31d1.htm EX-31.1 10068
3 EX-31.2 ptgx-20250331xex31d2.htm EX-31.2 10020
4 EX-32.1 ptgx-20250331xex32d1.htm EX-32.1 9981
5 GRAPHIC ptgx-20250331x10q007.jpg GRAPHIC 111253
  Complete submission text file 0001558370-25-006530.txt   5970175

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptgx-20250331.xsd EX-101.SCH 43495
7 EX-101.CAL ptgx-20250331_cal.xml EX-101.CAL 57313
8 EX-101.DEF ptgx-20250331_def.xml EX-101.DEF 136920
9 EX-101.LAB ptgx-20250331_lab.xml EX-101.LAB 304388
10 EX-101.PRE ptgx-20250331_pre.xml EX-101.PRE 237057
62 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20250331x10q_htm.xml XML 990574
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 25918192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)